Ki-67 expression in squamous intraepithelial lesions of the uterine cervix

Archive of Oncology

Volumn 14, Issue 1-2, 2006, Pages 23-25

  Panjković, Milana ^a   Ivkovic Kapicl, Tatjana ^b  

^a Institute of Pulmonary Diseases   (Serbia)

^b Institute of Oncology Sremska Kamenlca   (Serbia)

Author keywords

Cervical Intraepithelial Neoplasia; Cervix neoplasms; Immunohistochemistry; Ki 67 Antigen; Tumor Markers, Biological

Indexed keywords

KI 67 ANTIGEN;

ADULT; ARTICLE; CANCER GRADING; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; PRECANCER; PROTEIN EXPRESSION; UTERINE CERVIX; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM;

EID: 33748426361     PISSN: 03547310     EISSN: None     Source Type: Journal    
DOI: 10.2298/AOO0602023P     Document Type: Article

References (12)

1. Tjalma W, Weyler J, Pollefiet C, Bogers J, Marck VE, Dam P, et al. The evaluation of proliferate activity in CIN III and microinvasive cervical cancer and its role of recurrence. Eur J Obstet Gynecol Reproduct Biol 2001;94(2):270-5.
2. Duensing S, Lee LY, Duensing A. The human papilloma virus type 16 E6 i E7 oncoproteins cooperate to induce mitotic defect and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci 2000;97(18):10002-7.
3. Duensing S, Munger K. Centrosomes, genomic instability, and cervical carcinogenesis. Crit Rev Eukaryot Gene Expr 2003;13(1):9-23.
4. Kruse AJ, Skaland I, Janssen EA, Buhr-Wildhagen S, Klos J, Arends MJ, et al. Quantitative molecular parameters to identify low-risk and high-risk early lesions; role of markers of proliferate activity and differentaiion and Rb availability. Int J Gynecol Pathol 2004;23(2):95-6.
5. Klaes R, Friedrich T, Spitkosky D, Ridder R, Rudy W, Petry U, et al. Overexpression of p16 (INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92(2):276-84.
6. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998;153(6):1741-8.
7. Leeuwen AM, Pieters WJ, Hollema H, Burger MPM. Atypical mitotic figures and the mitotic index in cervical intraepithelial neoplasia. Virchows Arch 1995;427:139-44.
8. Xu M, Jin YL, Fu J, Huang H, Chen SZ, Ping Q, et al. The abnormal expression of retinoic acid receptor, p53 and Ki-67 protein in normal, premalignant and malignant esophageal tissues. World J Gastroenterol 2002;8(2):200-2.
9. Calore EE, Manzione CR, Nadal SR, Cavalieri MJ, Calore NMP, Santos RPI. Ki-67 expression in anal intraepithelial neoplasia in AIDS. Sao Paolo Med J 2001;119 (3):201-6.
10. Kruse AJ, Baak JPA, Bruin PC, Jiwa M, Snijders W, Boodt GF, et al. Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading. J Pathol 2001;193:48-54.
11. al-Saleh W, Delvenne P, Greimers R, Fridman V, Doyen J, Boniver J. Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Correlation with the histologic grade and human papillomavirus type. Am J Clin Pathol 1995;104(2):154-60.
12. Sahebali S, Depuydt CE, Segers K, Vereecken AJ, Marck EV, Bogers JJI. Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool? J Clin Pathol 2003;56:681-6.